<DOC>
	<DOCNO>NCT00519675</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy alitretinoin chronic hand eczema refractory topical corticosteroid .</brief_summary>
	<brief_title>Alitretinoin Treatment Chronic Hand Eczema</brief_title>
	<detailed_description>Chronic hand eczema frequent distress disease . The course disease chronic-relapsing nature . In phase III study alitretinoin clinically effective patient severe chronic hand eczema refractory topical treatment . This study investigate safety efficacy alitretinoin previously participate clinical trial involve alitretinoin .</detailed_description>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Alitretinoin</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>Previous participation therapeutic trial involve chronic hand eczema Relapse chronic hand eczema , define 75 % baseline initial total lesion symptom score Patients whose disease adequately control standard nonmedicated skin care topical corticosteroid therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Chronic hand eczema</keyword>
	<keyword>Chronic hand dermatitis</keyword>
	<keyword>Patients chronic hand eczema , refractory topical corticosteroid</keyword>
</DOC>